NeueHealth, Inc. (NEUE)
(Delayed Data from NYSE)
$6.42 USD
+0.12 (1.90%)
Updated May 8, 2024 03:58 PM ET
After-Market: $6.31 -0.11 (-1.71%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Income Statements
Fiscal Year end for NeueHealth, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,161 | 2,412 | 4,029 | 1,207 | 281 |
Cost Of Goods | 997 | 2,206 | 3,954 | 1,047 | 224 |
Gross Profit | 164 | 206 | 76 | 160 | 56 |
Selling & Adminstrative & Depr. & Amort Expenses | 741 | 828 | 1,274 | 418 | 182 |
Income After Depreciation & Amortization | -577 | -622 | -1,198 | -258 | -125 |
Non-Operating Income | -14 | 1 | 1 | 0 | 0 |
Interest Expense | 38 | 13 | 8 | 0 | 0 |
Pretax Income | -629 | -634 | -1,205 | -258 | -125 |
Income Taxes | -1 | 4 | -27 | -9 | 0 |
Minority Interest | -114 | 96 | 7 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -628 | -638 | -1,178 | -248 | -125 |
Extras & Discontinued Operations | -638 | -722 | 0 | 0 | 0 |
Net Income (GAAP) | -1,151 | -1,456 | -1,185 | -248 | -125 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 17 | -447 | -1,163 | -249 | -124 |
Depreciation & Amortization (Cash Flow) | 594 | 175 | 35 | 8 | 1 |
Income After Depreciation & Amortization | -577 | -622 | -1,198 | -258 | -125 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 7.95 | 7.85 | 4.90 | NA | NA |
Diluted EPS Before Non-Recurring Items | -17.62 | -86.40 | -241.60 | NA | NA |
Diluted Net EPS (GAAP) | -150.94 | -190.40 | -241.60 | -145.60 | NA |
Fiscal Year end for NeueHealth, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | -162.92 | 269.40 | 297.98 | 756.34 |
Cost Of Goods | NA | -163.53 | 226.44 | 245.16 | 688.52 |
Gross Profit | NA | 0.61 | 42.96 | 52.82 | 67.83 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 5.67 | 505.73 | 76.24 | 153.57 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.06 | -462.77 | -23.42 | -85.74 |
Non-Operating Income | NA | -4.10 | -9.87 | 0.00 | 0.00 |
Interest Expense | NA | 11.21 | 10.04 | 9.17 | 7.79 |
Pretax Income | NA | -20.36 | -482.69 | -32.58 | -93.53 |
Income Taxes | NA | 1.59 | -3.39 | -0.89 | 1.26 |
Minority Interest | NA | -230.86 | 86.75 | 24.21 | 5.55 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -21.95 | -479.31 | -31.69 | -94.79 |
Extras & Discontinued Operations | NA | -438.62 | -67.84 | -56.94 | -74.67 |
Net Income (GAAP) | NA | -229.72 | -633.90 | -112.83 | -175.01 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 7.95 | 7.98 | 7.96 | 7.89 |
Diluted EPS Before Non-Recurring Items | NA | 20.07 | -8.31 | -8.55 | -14.40 |
Diluted Net EPS (GAAP) | NA | -30.21 | -81.03 | -15.70 | -24.00 |